Tatyana S Konstantinova (T S Konstantinova, Tatiana Konstantinova)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Ejection Fraction

Multiple Myeloma

Top Venues

Terapevticheskii arkhiv

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Martin, Joseph R Mikhael, Roman Hájek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin, Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatyana S Konstantinova, Marie-Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde, Philippe Moreau
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma. Blood advances 6 (15) (2022)
Vadim V Ptushkin, M A Kunst, Tatyana A Mitina, Tatyana S Konstantinova, N N Rachkova, T V Shelekhova, I V Elykomov, G B Kuchma, K O Farizova, Olga Vinogradova, Eugene A Nikitin, E D Pashanov
[Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)]. Terapevticheskii arkhiv 94 (7) (2022)
Alexander Dmitrievich Kulagin, Vadim V Ptushkin, Elena A Lukina, Igor L Davydkin, Alexander V Korobkin, Vladimir S Shamrai, Tatyana S Konstantinova, Tatyana S Kaporskaya, Tatyana A Mitina, Tatyana I Ksenzova, Evgeny V Zuev, Oksana A Markova, Elena V Gapchenko, Dmitry Anatolievich Kudlay
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Annals of hematology 100 (11) (2021)
Alexander Dmitrievich Kulagin, Bulat A Bakirov, Igor L Davydkin, I V Elykomov, Tatyana S Konstantinova, Alexander V Korobkin, M V Kosinova, Vadim I Mazurov, N V Minaeva, A V Proidakov, Vadim V Ptushkin, Y V Shatokhin, Yulia N Linkova, Arina V Zinkina-Orikhan, Maria A Morozova
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial]. Terapevticheskii arkhiv 93 (11) (2021)
Vadim V Ptushkin, Alexander Dmitrievich Kulagin, Elena A Lukina, Igor L Davydkin, Tatyana S Konstantinova, Vladimir S Shamrai, N V Minaeva, Dmitry Anatolievich Kudlay, Elena V Gapchenko, Oksana A Markova, A Y Borozinets
[Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy]. Terapevticheskii arkhiv 92 (7) (2020)